Skip to content
Governance Register

← US public companies

Pliant Therapeutics, INC.

SEC CIK 1746473 · PLRX · last insider filing 2026-06-12

Directors (from insider filings)

NameCapacity as filedFilings
Crowell Gayle A Director filed 2020 - 2026
Huh Hoyoung Director filed 2020 - 2026
Mccourt Thomas A Director filed 2023 - 2026
Curnutte John T Director filed 2020 - 2026
Cline Darren S Director filed 2023 - 2026
Krognes Steve E. Director filed 2024 - 2026
Coulie Bernard Director · President and CEO filed 2020 - 2026
Pyott David E I Director filed 2021 - 2025
Bruhn Suzanne Louise Director filed 2020 - 2025
Knobil Katharine Director filed 2022 - 2025
Shah Smital Director filed 2020 - 2024
Exter Neil Director filed 2020 - 2022
Homcy Charles J Director filed 2020 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Cummings Keith Lamont Chief Financial Officer filed 2020 - 2026
Cheung Lily Chief Human Resource Officer filed 2023 - 2026
Kuo Minnie Chief Operating Officer filed 2025 - 2026
Lefebvre Eric Chief Medical Officer filed 2020 - 2025
Hull Hans Chief Business Officer filed 2020 - 2025
Ouimette Mike General Counsel & Corp. Sec'y filed 2020 - 2025
Howes Barbara Chief Human Resource Officer filed 2020 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.